Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    11914998 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed TAMOVALCIR in Allogenic Hematopoietic Progenitors Transplant
Condition: Cytomegalovirus Infection
Intervention: Drug: Valganciclovir

Study has passed its completion date and status has not been verified in more than two years.